Robert C. Ireton

1.4k total citations
29 papers, 1.1k citations indexed

About

Robert C. Ireton is a scholar working on Pulmonary and Respiratory Medicine, Urology and Surgery. According to data from OpenAlex, Robert C. Ireton has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Urology and 7 papers in Surgery. Recurrent topics in Robert C. Ireton's work include Atrial Fibrillation Management and Outcomes (6 papers), Urological Disorders and Treatments (5 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Robert C. Ireton is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Urological Disorders and Treatments (5 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Robert C. Ireton collaborates with scholars based in United States and United Kingdom. Robert C. Ireton's co-authors include Richard E. Berger, Oliver E. Cobb, Haakon Ragde, Victoria Bowes, M.J. Troychak, Alton L. Boynton, B.A. Tjoa, Gerald M. Kenny, G.P. Murphy and S.J. Simmons and has published in prestigious journals such as The Journal of Chemical Physics, Radiology and The Journal of Infectious Diseases.

In The Last Decade

Robert C. Ireton

28 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Ireton United States 16 446 265 239 199 191 29 1.1k
Steven R. Goldstein United States 38 351 0.8× 313 1.2× 445 1.9× 142 0.7× 62 0.3× 131 5.5k
William G. Simpson United States 18 104 0.2× 150 0.6× 127 0.5× 208 1.0× 47 0.2× 52 1.6k
Tai‐Wai Chin Taiwan 19 149 0.3× 115 0.4× 89 0.4× 96 0.5× 91 0.5× 72 1.1k
P Belitsky Canada 24 96 0.2× 177 0.7× 215 0.9× 215 1.1× 182 1.0× 99 2.1k
P. Deteix France 21 178 0.4× 257 1.0× 112 0.5× 211 1.1× 12 0.1× 71 1.4k
D C Dunn United Kingdom 14 186 0.4× 233 0.9× 216 0.9× 204 1.0× 19 0.1× 34 1.9k
A.S. Salinas Sánchez Spain 21 47 0.1× 550 2.1× 208 0.9× 210 1.1× 138 0.7× 150 1.5k
Jane Wu United States 13 147 0.3× 235 0.9× 545 2.3× 231 1.2× 22 0.1× 33 1.3k
Michael Chrisofos Greece 24 60 0.1× 195 0.7× 123 0.5× 188 0.9× 370 1.9× 101 1.5k
Seong Heon Kim South Korea 19 149 0.3× 393 1.5× 50 0.2× 107 0.5× 19 0.1× 107 1.1k

Countries citing papers authored by Robert C. Ireton

Since Specialization
Citations

This map shows the geographic impact of Robert C. Ireton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Ireton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Ireton more than expected).

Fields of papers citing papers by Robert C. Ireton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Ireton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Ireton. The network helps show where Robert C. Ireton may publish in the future.

Co-authorship network of co-authors of Robert C. Ireton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Ireton. A scholar is included among the top collaborators of Robert C. Ireton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Ireton. Robert C. Ireton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckman, Mark H., R. Wise, Anthony C. Leonard, et al.. (2023). Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?. Journal of Cardiology. 83(5). 285–290. 1 indexed citations
2.
Eckman, Mark H., Alexandru Costea, Mehran Attari, et al.. (2018). Shared decision-making tool for thromboprophylaxis in atrial fibrillation – A feasibility study. American Heart Journal. 199. 13–21. 19 indexed citations
3.
Eckman, Mark H., Alexandru Costea, Mehran Attari, et al.. (2017). Atrial fibrillation decision support tool: Population perspective. American Heart Journal. 194. 49–60. 7 indexed citations
4.
Eckman, Mark H., Gregory Y.H. Lip, R. Wise, et al.. (2016). Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation. American Heart Journal. 176. 17–27. 38 indexed citations
5.
Eckman, Mark H., Gregory Y.H. Lip, R. Wise, et al.. (2016). Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age. Journal of the American Geriatrics Society. 64(5). 1054–1060. 16 indexed citations
6.
Eckman, Mark H., R. Wise, Megan Sullivan, et al.. (2014). Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation. Circulation Cardiovascular Quality and Outcomes. 7(5). 680–686. 18 indexed citations
7.
8.
Tjoa, B.A., S.J. Simmons, Victoria Bowes, et al.. (1998). Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. The Prostate. 36(1). 39–44. 207 indexed citations
9.
Tjoa, B.A., Sheila J. Erickson, Victoria Bowes, et al.. (1997). Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. The Prostate. 32(4). 272–278. 103 indexed citations
10.
Abdel-Nabi, Hani, et al.. (1990). Clinical experience with intra lymphatic administration of111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 16(3). 149–156. 10 indexed citations
11.
Ireton, Robert C., et al.. (1990). Bladder Volume Determination Using a Dedicated, Portable Ultrasound Scanner. The Journal of Urology. 143(5). 909–911. 65 indexed citations
12.
Lowe, Marc A., et al.. (1990). A Comparison of Penile Brachial Index and Angiography: Evaluation of Corpora Cavernosa Arterial Inflow. The Journal of Urology. 143(3). 510–513. 15 indexed citations
13.
Jacobson, Louis, Charles Chabal, Michael C. Brody, Richard J. Ward, & Robert C. Ireton. (1989). Intrathecal Methadone and Morphine for Postoperative Analgesia. Anesthesiology. 70(5). 742–746. 30 indexed citations
14.
15.
Russell, Kenneth, Michel A. Boileau, Robert C. Ireton, et al.. (1988). Transitional cell carcinoma of the urinary bladder: histologic clearance with combined 5-FU chemotherapy and radiation therapy. Preliminary results of a bladder-preservation study.. Radiology. 167(3). 845–848. 10 indexed citations
16.
Ireton, Robert C., Randall M. Parker, & Patricia W. Hayden. (1987). Diuretic renography in evaluating dilated upper urinary tract in children. Urology. 29(2). 178–184. 7 indexed citations
17.
Ireton, Robert C. & Richard E. Berger. (1984). Prostatitis and Epididymitis. Urologic Clinics of North America. 11(1). 83–94. 22 indexed citations
18.
Berger, Richard E. & Robert C. Ireton. (1983). Combined Infrapubic and Retropubic Ligation of the Dorsal Vein of the Penis During Radical Retropubic Surgery. The Journal of Urology. 130(6). 1107–1109. 4 indexed citations
19.
Moore, William M. & Robert C. Ireton. (1977). THE PHOTOCHEMISTRY OF RIBOFLAVIN—V. THE PHOTODEGRADATION OF ISOALLOXAZINES IN ALCOHOLIC SOLVENTS. Photochemistry and Photobiology. 25(4). 347–356. 40 indexed citations
20.
Rabinovitch, B. S., et al.. (1973). Test of RRKM theory. Rates of decomposition in the series of chemically activated 2-n-alkyl radicals from C4 to C16. The Journal of Chemical Physics. 58(1). 340–348. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven R. Goldstein Breakdown of academic impact, for papers by William G. Simpson Breakdown of academic impact, for papers by Tai‐Wai Chin Breakdown of academic impact, for papers by P Belitsky Breakdown of academic impact, for papers by P. Deteix Breakdown of academic impact, for papers by D C Dunn Breakdown of academic impact, for papers by A.S. Salinas Sánchez Breakdown of academic impact, for papers by Jane Wu Breakdown of academic impact, for papers by Michael Chrisofos Breakdown of academic impact, for papers by Seong Heon Kim
Rankless by CCL
2026